NIH Public Access Author Manuscript Oncogene. Author manuscript; available in PMC 2011 September 20. Published in final edited form as: Oncogene. 2010 August 26; 29(34): 4741–4751. doi:10.1038/onc.2010.215.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer Anurag Singh1 and Jeffrey Settleman1 1Massachusetts General Hospital Cancer Center and Harvard Medical School, 149 13thStreet, Charlestown, MA 02129, USA
Abstract Tumors are cellularly and moleculary heterogeneous, with subsets of undifferentiated cancer cells exhibiting stem cell-like features (CSCs). Epithelial to mesenchymal transitions (EMT) are transdifferentiation programs that are required for tissue morphogenesis during embryonic development. The EMT process can be regulated by a diverse array of cytokines and growth factors, such as TGF-β whose activities are dysregulated during malignant tumor progression. Thus, EMT induction in cancer cells results in the acquisition of invasive and metastatic properties. Recent reports indicate that the emergence of CSCs occurs in part as a result of EMT, for example, via cues from tumor stromal components. Recent evidence now indicates that EMT of tumor cells not only causes increased metastasis but also contributes to drug resistance. In this review, we will provide potential mechanistic explanations for the association between EMT induction and the emergence of CSCs. We will also highlight recent studies implicating the function of TGF-β regulated non-coding RNAs in driving EMT and promoting CSC self-renewal. Finally we will discuss how EMT and CSCs may contribute to drug resistance as well as therapeutic strategies to overcome this clinically.
Introduction Cellular heterogeneity is a histological hallmark of many cancers (Pardal et al., 2003). Despite their clonal origin, tumors are comprised of cells with varied morphological and molecular features. Rare tumor-initiating cells with stem cell-like properties in both hematopoietic and solid malignancies have been identified and classified using distinct cell surface markers. These cancer stem cells (CSCs) can self-renew and differentiate to generate the cellular heterogeneity of the originating tumor (Al-Hajj et al., 2003; Hermann et al., 2007; Lapidot et al., 1994; O’Brien et al., 2007; Ricci-Vitiani et al., 2007; Singh et al., 2004). However, whether CSCs are truly the only cells with de facto tumorigenic potential remains controversial (Gupta et al., 2009a; Quintana et al., 2008). Regardless, tumors are clearly histologically heterogenous, with subsets of cancer cells exhibiting distinct molecular profiles (Gupta et al., 2009a). Furthermore, cells with different molecular characteristics within the same tumor respond differently to anti-cancer therapeutics, leading to drug resistance (Zhou et al., 2009). Cancer cells may also undergo adaptive changes following therapy, e
xacerbating drug resistance. In epithelial cancers, these adaptive changes may involve, at least in part, epithelial to mesenchymal transitions (EMT) and the reverse process (MET). These are developmental programs that can be usurped by oncogenically transformed cells during tumor progression (Thiery et al., 2009).
Correspondence to: Jeffrey Settleman.

Drug Resistance Updates 13 (2010) 109–118 Contents lists available at ...EMT, cancer stem cells and drug resistance: an emerging axis of evil in ...
1.EMT and cancer stem cells 初稿_法律资料_人文社科_专业资料。eoeo第十一章 恶性肿瘤上皮间质转化与肿瘤干细胞………王冠军(李薇) 第一节 基本概念 1.上...
induced by different factors are rich sources for cancer stem-like cells....only promotes invasion and metastasis but also contributes to drug resistance....
(EMT), with lower expression of epithelial ...one of the origins of breast cancer stem cells....colonies were oval, the long axis was measured....
EMT regulator slug and lung carcinogenesis Jin-Yuan Shih and Pan-Chyr Yang...(2010) EMT, cancer stem cells and drug resistance: an emerging axis of ...
cancer stem cells and breast cancer cells S ...resistance to apoptosis and chemotherapy (Thiery et...(2012) Non-canonical Notch signaling: emerging ...
cient elimination of breast cancer stem cells (...Metastasis, chemotherapeutic resistance and ...et al. Nanocarriers as an emerging platform for ...
transition ,EMT)通常与肿瘤干细胞存在极为密切的联系。 Her- Notch ,Hedgehog ...ABC transporters, drug resistance, and cancer stem cells [J]. J Mammary ...
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene. 2010 Aug 26;29(34):4741-51. 28. Dong P,...
热门文档